APO Research
Talk to an analyst

APO RESEARCH · REPORT

Donepezil Hydrochloride Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Donepezil Hydrochloride Tablets Market Outlook and Growth Opportunities 2026

29 December 2025217 pages

Choose your research edition.

Industry ResearchDonepezil Hydrochloride Tablets Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Donepezil Hydrochloride Tablets Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Donepezil Hydrochloride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Donepezil Hydrochloride Tablets Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Donepezil Hydrochloride Tablets Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Donepezil Hydrochloride Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Donepezil Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Donepezil Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Donepezil Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Donepezil Hydrochloride Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Donepezil Hydrochloride Tablets market include Zein Biotechnology, Zhejiang Huahai Pharmaceutical, Yangtze River Pharmaceutical, Tianjin Lisheng Pharmaceutical, Sichuan Sunnyhope Pharmaceutical, Shaanxi Ark Pharmaceutical, Shandong Fangming Pharmaceutical, Goldensun Pharmaceutical and Hansoh Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Donepezil Hydrochloride Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Donepezil Hydrochloride Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Donepezil Hydrochloride Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Donepezil Hydrochloride Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Donepezil Hydrochloride Tablets Segment by Company

Zein Biotechnology

Zhejiang Huahai Pharmaceutical

Yangtze River Pharmaceutical

Tianjin Lisheng Pharmaceutical

Sichuan Sunnyhope Pharmaceutical

Shaanxi Ark Pharmaceutical

Shandong Fangming Pharmaceutical

Goldensun Pharmaceutical

Hansoh Pharma

Hisun Pharmaceuticals

Furen Medicines

Disha Pharmaceutical

Zydus

Torrent Pharmaceuticals

Strides Pharma

Macleods Pharmaceuticals

Lupin

Hetero

Eisai

Dr. Reddy's Laboratories

Cipla

Chartwell

Cadila Pharmaceuticals

Aurobindo Pharma

Alembic

Donepezil Hydrochloride Tablets Segment by Type

Orally Disintegrating Tablets

Immediate-release Tablets

Donepezil Hydrochloride Tablets Segment by Application

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Donepezil Hydrochloride Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Donepezil Hydrochloride Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Donepezil Hydrochloride Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Donepezil Hydrochloride Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Donepezil Hydrochloride Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Donepezil Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil Hydrochloride Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Donepezil Hydrochloride Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Donepezil Hydrochloride Tablets industry.

Chapter 3: Detailed analysis of Donepezil Hydrochloride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Donepezil Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Donepezil Hydrochloride Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Donepezil Hydrochloride Tablets Industry Trends Table 2. Donepezil Hydrochloride Tablets Industry Drivers Table 3. Donepezil Hydrochloride Tablets Industry Opportunities and Challenges Table 4. Donepezil Hydrochloride Tablets Industry Restraints Table 5. Global Donepezil Hydrochloride Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Donepezil Hydrochloride Tablets Revenue Share by Company (2021-2026) Table 7. Global Donepezil Hydrochloride Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Donepezil Hydrochloride Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Donepezil Hydrochloride Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Donepezil Hydrochloride Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Donepezil Hydrochloride Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Donepezil Hydrochloride Tablets Company, Product Type & Application Table 13. Global Donepezil Hydrochloride Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Donepezil Hydrochloride Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Orally Disintegrating Tablets Table 18. Significant Companies of Immediate-release Tablets Table 19. Global Donepezil Hydrochloride Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Donepezil Hydrochloride Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Donepezil Hydrochloride Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Donepezil Hydrochloride Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Donepezil Hydrochloride Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Donepezil Hydrochloride Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Donepezil Hydrochloride Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Donepezil Hydrochloride Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Donepezil Hydrochloride Tablets Sales Value Share by Type (2021-2026) Table 28. Global Donepezil Hydrochloride Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retail Pharmacy Table 30. Significant Companies of Hospital Pharmacy Table 31. Significant Companies of Online Pharmacy Table 32. Global Donepezil Hydrochloride Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Donepezil Hydrochloride Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Donepezil Hydrochloride Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Donepezil Hydrochloride Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Donepezil Hydrochloride Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Donepezil Hydrochloride Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Donepezil Hydrochloride Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Donepezil Hydrochloride Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Donepezil Hydrochloride Tablets Sales Value Share by Application (2021-2026) Table 41. Global Donepezil Hydrochloride Tablets Sales Value Share by Application (2027-2032) Table 42. Global Donepezil Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Donepezil Hydrochloride Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Donepezil Hydrochloride Tablets Sales Market Share by Region (2021-2026) Table 45. Global Donepezil Hydrochloride Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Donepezil Hydrochloride Tablets Sales Market Share by Region (2027-2032) Table 47. Global Donepezil Hydrochloride Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Donepezil Hydrochloride Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Donepezil Hydrochloride Tablets Sales Value Share by Region (2021-2026) Table 50. Global Donepezil Hydrochloride Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Donepezil Hydrochloride Tablets Sales Value Share by Region (2027-2032) Table 52. Global Donepezil Hydrochloride Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Donepezil Hydrochloride Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Donepezil Hydrochloride Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Donepezil Hydrochloride Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Donepezil Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Donepezil Hydrochloride Tablets Sales Market Share by Country (2021-2026) Table 58. Global Donepezil Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Donepezil Hydrochloride Tablets Sales Market Share by Country (2027-2032) Table 60. Global Donepezil Hydrochloride Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Donepezil Hydrochloride Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Donepezil Hydrochloride Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Donepezil Hydrochloride Tablets Sales Value Market Share by Country (2027-2032) Table 64. Zein Biotechnology Company Information Table 65. Zein Biotechnology Business Overview Table 66. Zein Biotechnology Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Zein Biotechnology Donepezil Hydrochloride Tablets Product Portfolio Table 68. Zein Biotechnology Recent Development Table 69. Zhejiang Huahai Pharmaceutical Company Information Table 70. Zhejiang Huahai Pharmaceutical Business Overview Table 71. Zhejiang Huahai Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Zhejiang Huahai Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 73. Zhejiang Huahai Pharmaceutical Recent Development Table 74. Yangtze River Pharmaceutical Company Information Table 75. Yangtze River Pharmaceutical Business Overview Table 76. Yangtze River Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Yangtze River Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 78. Yangtze River Pharmaceutical Recent Development Table 79. Tianjin Lisheng Pharmaceutical Company Information Table 80. Tianjin Lisheng Pharmaceutical Business Overview Table 81. Tianjin Lisheng Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Tianjin Lisheng Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 83. Tianjin Lisheng Pharmaceutical Recent Development Table 84. Sichuan Sunnyhope Pharmaceutical Company Information Table 85. Sichuan Sunnyhope Pharmaceutical Business Overview Table 86. Sichuan Sunnyhope Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sichuan Sunnyhope Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 88. Sichuan Sunnyhope Pharmaceutical Recent Development Table 89. Shaanxi Ark Pharmaceutical Company Information Table 90. Shaanxi Ark Pharmaceutical Business Overview Table 91. Shaanxi Ark Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Shaanxi Ark Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 93. Shaanxi Ark Pharmaceutical Recent Development Table 94. Shandong Fangming Pharmaceutical Company Information Table 95. Shandong Fangming Pharmaceutical Business Overview Table 96. Shandong Fangming Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Shandong Fangming Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 98. Shandong Fangming Pharmaceutical Recent Development Table 99. Goldensun Pharmaceutical Company Information Table 100. Goldensun Pharmaceutical Business Overview Table 101. Goldensun Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Goldensun Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 103. Goldensun Pharmaceutical Recent Development Table 104. Hansoh Pharma Company Information Table 105. Hansoh Pharma Business Overview Table 106. Hansoh Pharma Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Hansoh Pharma Donepezil Hydrochloride Tablets Product Portfolio Table 108. Hansoh Pharma Recent Development Table 109. Hisun Pharmaceuticals Company Information Table 110. Hisun Pharmaceuticals Business Overview Table 111. Hisun Pharmaceuticals Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hisun Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio Table 113. Hisun Pharmaceuticals Recent Development Table 114. Furen Medicines Company Information Table 115. Furen Medicines Business Overview Table 116. Furen Medicines Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Furen Medicines Donepezil Hydrochloride Tablets Product Portfolio Table 118. Furen Medicines Recent Development Table 119. Disha Pharmaceutical Company Information Table 120. Disha Pharmaceutical Business Overview Table 121. Disha Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Disha Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 123. Disha Pharmaceutical Recent Development Table 124. Zydus Company Information Table 125. Zydus Business Overview Table 126. Zydus Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Zydus Donepezil Hydrochloride Tablets Product Portfolio Table 128. Zydus Recent Development Table 129. Torrent Pharmaceuticals Company Information Table 130. Torrent Pharmaceuticals Business Overview Table 131. Torrent Pharmaceuticals Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Torrent Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio Table 133. Torrent Pharmaceuticals Recent Development Table 134. Strides Pharma Company Information Table 135. Strides Pharma Business Overview Table 136. Strides Pharma Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Strides Pharma Donepezil Hydrochloride Tablets Product Portfolio Table 138. Strides Pharma Recent Development Table 139. Macleods Pharmaceuticals Company Information Table 140. Macleods Pharmaceuticals Business Overview Table 141. Macleods Pharmaceuticals Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Macleods Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio Table 143. Macleods Pharmaceuticals Recent Development Table 144. Lupin Company Information Table 145. Lupin Business Overview Table 146. Lupin Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Lupin Donepezil Hydrochloride Tablets Product Portfolio Table 148. Lupin Recent Development Table 149. Hetero Company Information Table 150. Hetero Business Overview Table 151. Hetero Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Hetero Donepezil Hydrochloride Tablets Product Portfolio Table 153. Hetero Recent Development Table 154. Eisai Company Information Table 155. Eisai Business Overview Table 156. Eisai Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Eisai Donepezil Hydrochloride Tablets Product Portfolio Table 158. Eisai Recent Development Table 159. Dr. Reddy's Laboratories Company Information Table 160. Dr. Reddy's Laboratories Business Overview Table 161. Dr. Reddy's Laboratories Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Dr. Reddy's Laboratories Donepezil Hydrochloride Tablets Product Portfolio Table 163. Dr. Reddy's Laboratories Recent Development Table 164. Cipla Company Information Table 165. Cipla Business Overview Table 166. Cipla Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Cipla Donepezil Hydrochloride Tablets Product Portfolio Table 168. Cipla Recent Development Table 169. Chartwell Company Information Table 170. Chartwell Business Overview Table 171. Chartwell Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Chartwell Donepezil Hydrochloride Tablets Product Portfolio Table 173. Chartwell Recent Development Table 174. Cadila Pharmaceuticals Company Information Table 175. Cadila Pharmaceuticals Business Overview Table 176. Cadila Pharmaceuticals Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Cadila Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio Table 178. Cadila Pharmaceuticals Recent Development Table 179. Aurobindo Pharma Company Information Table 180. Aurobindo Pharma Business Overview Table 181. Aurobindo Pharma Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. Aurobindo Pharma Donepezil Hydrochloride Tablets Product Portfolio Table 183. Aurobindo Pharma Recent Development Table 184. Alembic Company Information Table 185. Alembic Business Overview Table 186. Alembic Donepezil Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 187. Alembic Donepezil Hydrochloride Tablets Product Portfolio Table 188. Alembic Recent Development Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Donepezil Hydrochloride Tablets Distributors List Table 192. Donepezil Hydrochloride Tablets Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Donepezil Hydrochloride Tablets Product Image Figure 2. Global Donepezil Hydrochloride Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Donepezil Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Donepezil Hydrochloride Tablets Sales (2021-2032) & (K Units) Figure 5. Global Donepezil Hydrochloride Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Donepezil Hydrochloride Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Orally Disintegrating Tablets Image Figure 10. Immediate-release Tablets Image Figure 11. Global Donepezil Hydrochloride Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Donepezil Hydrochloride Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Donepezil Hydrochloride Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Donepezil Hydrochloride Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Donepezil Hydrochloride Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Donepezil Hydrochloride Tablets Sales Value Share by Type (2021-2032) Figure 17. Retail Pharmacy Image Figure 18. Hospital Pharmacy Image Figure 19. Online Pharmacy Image Figure 20. Global Donepezil Hydrochloride Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Donepezil Hydrochloride Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Donepezil Hydrochloride Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Donepezil Hydrochloride Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Donepezil Hydrochloride Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Donepezil Hydrochloride Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Donepezil Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Donepezil Hydrochloride Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Donepezil Hydrochloride Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Donepezil Hydrochloride Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Donepezil Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Donepezil Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Donepezil Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Donepezil Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Donepezil Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Donepezil Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Donepezil Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Donepezil Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Donepezil Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Donepezil Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Donepezil Hydrochloride Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Donepezil Hydrochloride Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Orally Disintegrating Tablets
  • Immediate-release Tablets
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • Zein Biotechnology
  • Zhejiang Huahai Pharmaceutical
  • Yangtze River Pharmaceutical
  • Tianjin Lisheng Pharmaceutical
  • Sichuan Sunnyhope Pharmaceutical
  • Shaanxi Ark Pharmaceutical
  • Shandong Fangming Pharmaceutical
  • Goldensun Pharmaceutical
  • Hansoh Pharma
  • Hisun Pharmaceuticals
  • Furen Medicines
  • Disha Pharmaceutical
  • Zydus
  • Torrent Pharmaceuticals
  • Strides Pharma
  • Macleods Pharmaceuticals
  • Lupin
  • Hetero
  • Eisai
  • Dr. Reddy's Laboratories
  • Cipla
  • Chartwell
  • Cadila Pharmaceuticals
  • Aurobindo Pharma
  • Alembic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Donepezil Hydrochloride Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Donepezil Hydrochloride Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Donepezil Hydrochloride Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Donepezil Hydrochloride Tablets Market Dynamics
  1. 2.1 Donepezil Hydrochloride Tablets Industry Trends
  2. 2.2 Donepezil Hydrochloride Tablets Industry Drivers
  3. 2.3 Donepezil Hydrochloride Tablets Industry Opportunities and Challenges
  4. 2.4 Donepezil Hydrochloride Tablets Industry Restraints
3 Donepezil Hydrochloride Tablets Market by Company
  1. 3.1 Global Donepezil Hydrochloride Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Donepezil Hydrochloride Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Donepezil Hydrochloride Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Donepezil Hydrochloride Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Donepezil Hydrochloride Tablets Company Ranking (2024-2026)
  6. 3.6 Global Donepezil Hydrochloride Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Donepezil Hydrochloride Tablets Company Product Type and Application
  8. 3.8 Global Donepezil Hydrochloride Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Donepezil Hydrochloride Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Donepezil Hydrochloride Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Donepezil Hydrochloride Tablets Market by Type
  1. 4.1 Donepezil Hydrochloride Tablets Type Introduction
  2. 4.1.1 Orally Disintegrating Tablets
  3. 4.1.2 Immediate-release Tablets
  4. 4.2 Global Donepezil Hydrochloride Tablets Sales Volume by Type
  5. 4.2.1 Global Donepezil Hydrochloride Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Donepezil Hydrochloride Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Donepezil Hydrochloride Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Donepezil Hydrochloride Tablets Sales Value by Type
  9. 4.3.1 Global Donepezil Hydrochloride Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Donepezil Hydrochloride Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Donepezil Hydrochloride Tablets Sales Value Share by Type (2021-2032)
5 Donepezil Hydrochloride Tablets Market by Application
  1. 5.1 Donepezil Hydrochloride Tablets Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Online Pharmacy
  5. 5.2 Global Donepezil Hydrochloride Tablets Sales Volume by Application
  6. 5.2.1 Global Donepezil Hydrochloride Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Donepezil Hydrochloride Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Donepezil Hydrochloride Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Donepezil Hydrochloride Tablets Sales Value by Application
  10. 5.3.1 Global Donepezil Hydrochloride Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Donepezil Hydrochloride Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Donepezil Hydrochloride Tablets Sales Value Share by Application (2021-2032)
6 Donepezil Hydrochloride Tablets Regional Sales and Value Analysis
  1. 6.1 Global Donepezil Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Donepezil Hydrochloride Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Donepezil Hydrochloride Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Donepezil Hydrochloride Tablets Sales by Region (2027-2032)
  5. 6.3 Global Donepezil Hydrochloride Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Donepezil Hydrochloride Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Donepezil Hydrochloride Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Donepezil Hydrochloride Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Donepezil Hydrochloride Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Donepezil Hydrochloride Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Donepezil Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Donepezil Hydrochloride Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Donepezil Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Donepezil Hydrochloride Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Donepezil Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Donepezil Hydrochloride Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Donepezil Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Donepezil Hydrochloride Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Donepezil Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
7 Donepezil Hydrochloride Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Donepezil Hydrochloride Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Donepezil Hydrochloride Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Donepezil Hydrochloride Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Donepezil Hydrochloride Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Donepezil Hydrochloride Tablets Sales by Country (2027-2032)
  6. 7.4 Global Donepezil Hydrochloride Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Donepezil Hydrochloride Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Donepezil Hydrochloride Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Donepezil Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Donepezil Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Donepezil Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zein Biotechnology
  2. 8.1.1 Zein Biotechnology Company Information
  3. 8.1.2 Zein Biotechnology Business Overview
  4. 8.1.3 Zein Biotechnology Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zein Biotechnology Donepezil Hydrochloride Tablets Product Portfolio
  6. 8.1.5 Zein Biotechnology Recent Developments
  7. 8.2 Zhejiang Huahai Pharmaceutical
  8. 8.2.1 Zhejiang Huahai Pharmaceutical Company Information
  9. 8.2.2 Zhejiang Huahai Pharmaceutical Business Overview
  10. 8.2.3 Zhejiang Huahai Pharmaceutical Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Huahai Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  12. 8.2.5 Zhejiang Huahai Pharmaceutical Recent Developments
  13. 8.3 Yangtze River Pharmaceutical
  14. 8.3.1 Yangtze River Pharmaceutical Company Information
  15. 8.3.2 Yangtze River Pharmaceutical Business Overview
  16. 8.3.3 Yangtze River Pharmaceutical Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Yangtze River Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  18. 8.3.5 Yangtze River Pharmaceutical Recent Developments
  19. 8.4 Tianjin Lisheng Pharmaceutical
  20. 8.4.1 Tianjin Lisheng Pharmaceutical Company Information
  21. 8.4.2 Tianjin Lisheng Pharmaceutical Business Overview
  22. 8.4.3 Tianjin Lisheng Pharmaceutical Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tianjin Lisheng Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  24. 8.4.5 Tianjin Lisheng Pharmaceutical Recent Developments
  25. 8.5 Sichuan Sunnyhope Pharmaceutical
  26. 8.5.1 Sichuan Sunnyhope Pharmaceutical Company Information
  27. 8.5.2 Sichuan Sunnyhope Pharmaceutical Business Overview
  28. 8.5.3 Sichuan Sunnyhope Pharmaceutical Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sichuan Sunnyhope Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  30. 8.5.5 Sichuan Sunnyhope Pharmaceutical Recent Developments
  31. 8.6 Shaanxi Ark Pharmaceutical
  32. 8.6.1 Shaanxi Ark Pharmaceutical Company Information
  33. 8.6.2 Shaanxi Ark Pharmaceutical Business Overview
  34. 8.6.3 Shaanxi Ark Pharmaceutical Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shaanxi Ark Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  36. 8.6.5 Shaanxi Ark Pharmaceutical Recent Developments
  37. 8.7 Shandong Fangming Pharmaceutical
  38. 8.7.1 Shandong Fangming Pharmaceutical Company Information
  39. 8.7.2 Shandong Fangming Pharmaceutical Business Overview
  40. 8.7.3 Shandong Fangming Pharmaceutical Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shandong Fangming Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  42. 8.7.5 Shandong Fangming Pharmaceutical Recent Developments
  43. 8.8 Goldensun Pharmaceutical
  44. 8.8.1 Goldensun Pharmaceutical Company Information
  45. 8.8.2 Goldensun Pharmaceutical Business Overview
  46. 8.8.3 Goldensun Pharmaceutical Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Goldensun Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  48. 8.8.5 Goldensun Pharmaceutical Recent Developments
  49. 8.9 Hansoh Pharma
  50. 8.9.1 Hansoh Pharma Company Information
  51. 8.9.2 Hansoh Pharma Business Overview
  52. 8.9.3 Hansoh Pharma Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hansoh Pharma Donepezil Hydrochloride Tablets Product Portfolio
  54. 8.9.5 Hansoh Pharma Recent Developments
  55. 8.10 Hisun Pharmaceuticals
  56. 8.10.1 Hisun Pharmaceuticals Company Information
  57. 8.10.2 Hisun Pharmaceuticals Business Overview
  58. 8.10.3 Hisun Pharmaceuticals Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hisun Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio
  60. 8.10.5 Hisun Pharmaceuticals Recent Developments
  61. 8.11 Furen Medicines
  62. 8.11.1 Furen Medicines Company Information
  63. 8.11.2 Furen Medicines Business Overview
  64. 8.11.3 Furen Medicines Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Furen Medicines Donepezil Hydrochloride Tablets Product Portfolio
  66. 8.11.5 Furen Medicines Recent Developments
  67. 8.12 Disha Pharmaceutical
  68. 8.12.1 Disha Pharmaceutical Company Information
  69. 8.12.2 Disha Pharmaceutical Business Overview
  70. 8.12.3 Disha Pharmaceutical Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Disha Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  72. 8.12.5 Disha Pharmaceutical Recent Developments
  73. 8.13 Zydus
  74. 8.13.1 Zydus Company Information
  75. 8.13.2 Zydus Business Overview
  76. 8.13.3 Zydus Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Zydus Donepezil Hydrochloride Tablets Product Portfolio
  78. 8.13.5 Zydus Recent Developments
  79. 8.14 Torrent Pharmaceuticals
  80. 8.14.1 Torrent Pharmaceuticals Company Information
  81. 8.14.2 Torrent Pharmaceuticals Business Overview
  82. 8.14.3 Torrent Pharmaceuticals Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Torrent Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio
  84. 8.14.5 Torrent Pharmaceuticals Recent Developments
  85. 8.15 Strides Pharma
  86. 8.15.1 Strides Pharma Company Information
  87. 8.15.2 Strides Pharma Business Overview
  88. 8.15.3 Strides Pharma Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Strides Pharma Donepezil Hydrochloride Tablets Product Portfolio
  90. 8.15.5 Strides Pharma Recent Developments
  91. 8.16 Macleods Pharmaceuticals
  92. 8.16.1 Macleods Pharmaceuticals Company Information
  93. 8.16.2 Macleods Pharmaceuticals Business Overview
  94. 8.16.3 Macleods Pharmaceuticals Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Macleods Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio
  96. 8.16.5 Macleods Pharmaceuticals Recent Developments
  97. 8.17 Lupin
  98. 8.17.1 Lupin Company Information
  99. 8.17.2 Lupin Business Overview
  100. 8.17.3 Lupin Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Lupin Donepezil Hydrochloride Tablets Product Portfolio
  102. 8.17.5 Lupin Recent Developments
  103. 8.18 Hetero
  104. 8.18.1 Hetero Company Information
  105. 8.18.2 Hetero Business Overview
  106. 8.18.3 Hetero Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Hetero Donepezil Hydrochloride Tablets Product Portfolio
  108. 8.18.5 Hetero Recent Developments
  109. 8.19 Eisai
  110. 8.19.1 Eisai Company Information
  111. 8.19.2 Eisai Business Overview
  112. 8.19.3 Eisai Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Eisai Donepezil Hydrochloride Tablets Product Portfolio
  114. 8.19.5 Eisai Recent Developments
  115. 8.20 Dr. Reddy's Laboratories
  116. 8.20.1 Dr. Reddy's Laboratories Company Information
  117. 8.20.2 Dr. Reddy's Laboratories Business Overview
  118. 8.20.3 Dr. Reddy's Laboratories Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Dr. Reddy's Laboratories Donepezil Hydrochloride Tablets Product Portfolio
  120. 8.20.5 Dr. Reddy's Laboratories Recent Developments
  121. 8.21 Cipla
  122. 8.21.1 Cipla Company Information
  123. 8.21.2 Cipla Business Overview
  124. 8.21.3 Cipla Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Cipla Donepezil Hydrochloride Tablets Product Portfolio
  126. 8.21.5 Cipla Recent Developments
  127. 8.22 Chartwell
  128. 8.22.1 Chartwell Company Information
  129. 8.22.2 Chartwell Business Overview
  130. 8.22.3 Chartwell Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Chartwell Donepezil Hydrochloride Tablets Product Portfolio
  132. 8.22.5 Chartwell Recent Developments
  133. 8.23 Cadila Pharmaceuticals
  134. 8.23.1 Cadila Pharmaceuticals Company Information
  135. 8.23.2 Cadila Pharmaceuticals Business Overview
  136. 8.23.3 Cadila Pharmaceuticals Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Cadila Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio
  138. 8.23.5 Cadila Pharmaceuticals Recent Developments
  139. 8.24 Aurobindo Pharma
  140. 8.24.1 Aurobindo Pharma Company Information
  141. 8.24.2 Aurobindo Pharma Business Overview
  142. 8.24.3 Aurobindo Pharma Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Aurobindo Pharma Donepezil Hydrochloride Tablets Product Portfolio
  144. 8.24.5 Aurobindo Pharma Recent Developments
  145. 8.25 Alembic
  146. 8.25.1 Alembic Company Information
  147. 8.25.2 Alembic Business Overview
  148. 8.25.3 Alembic Donepezil Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Alembic Donepezil Hydrochloride Tablets Product Portfolio
  150. 8.25.5 Alembic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Donepezil Hydrochloride Tablets Value Chain Analysis
  2. 9.1.1 Donepezil Hydrochloride Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Donepezil Hydrochloride Tablets Sales Mode & Process
  6. 9.2 Donepezil Hydrochloride Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Donepezil Hydrochloride Tablets Distributors
  9. 9.2.3 Donepezil Hydrochloride Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst